Cancer Treatment in India:
Cost and Hospitals in Gujarat

Principally the treatment type — surgery, chemotherapy, radiotherapy or a combination — and, for chemotherapy, the specific regimen indicated for the cancer. Regimens using targeted therapy or immunotherapy cost considerably more than conventional chemotherapy. The tumour’s pathology and molecular profile often determine which drugs are appropriate, and therefore the cost.

Three months typically covers three to six cycles, as cycles repeat every two to four weeks. Cost depends far more on which regimen is used than on duration — a conventional regimen and one incorporating targeted biologics can differ several times over for the same period. The oncologist confirms the regimen after reviewing pathology.

The infusion itself is not painful — the drug is given through a vein or an implanted port, similar to a drip. Discomfort arises afterwards and may include nausea, fatigue, mouth soreness or nerve tingling. Anti-emetic and supportive medication controls most of these, and the regimen can be adjusted if side effects become severe.

At every stage, for different purposes. Before surgery it can shrink a tumour; after surgery it clears residual disease; in advanced disease it controls spread and relieves symptoms. Stage alone does not determine its use — tumour type, grade and molecular markers do.

No. Stage 4 indicates the cancer has spread beyond its site of origin, not that treatment is futile. Several stage 4 cancers respond well to modern targeted and immune therapies, and many patients live for years with the disease controlled. Prognosis depends heavily on cancer type and molecular profile rather than on stage alone.

No, and outcomes vary considerably with the underlying disease, the patient’s age and fitness, and how closely the donor matches. Results are generally better for autologous transplants and for well-matched related donors. Graft-versus-host disease and infection are the principal risks in the months following an allogeneic transplant.

The Gujarat Cancer & Research Institute in Ahmedabad is a government-backed regional cancer centre and among the largest in the state, within the GMVTPS network alongside HCG Aastha Cancer Centre and accredited multi-speciality hospitals with oncology departments. The most appropriate centre depends on the cancer type, as expertise varies by tumour.